PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Digital training programme improves quality of life for dementia patients living in care

The programme is the only remote, digital delivery nursing home training programme for dementia.

King’s College London and the University of Exeter have announced that their digital training programme, iWHELD, significantly improved the quality of life for people living with dementia in residential and nursing home care.

The programme was specifically adapted to COVID-19 restrictions to support homes throughout the pandemic, improve care and share best practices.
Dementia is a progressive neurodegenerative disorder that affects more than 944,000 people in the UK.

iWHELD is designed to improve support for carers and residents by training staff in delivering personalised care and can be delivered remotely with support available for care home staff.

Funded by UK Research and Innovation and published in the journal of the Alzheimer’s Association, the 16-week randomised controlled trial supported over 700 care residents living with dementia across 149 UK residential homes.

When compared to usual care, researchers found that iWHELD particularly benefitted patients who contracted COVID-19, those who showed signs of agitation when the study began and those taking psychiatric medications.

Results from the trial showed that the quality of life substantially improved after staff took part in the programme and also led to a significant drop in the prescription of potentially harmful sedative medications to residents.

The training programme is currently the only remote, digital delivery nursing home training programme available for dementia care, which offers valuable, pandemic-safe tools for improving care.

Professor Clive Ballard, University of Exeter Medical School, said: “People with dementia living in residential and nursing home care are among the most vulnerable in society.

“iWHELD is an effective, practical and affordable programme that can enable staff to improve the lives of people with dementia and can be delivered nationally and internationally – even amidst a pandemic.”

Joanne McDermid, dementia care researcher at the University of Exeter and creator of the iWHELD platform, said: “It’s the first programme to… address the needs of care and nursing homes and critically, to improve the lives of the people with dementia.”

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026